Dr. Drapkin

	Department of Pathology
	Brigham and Women's Hospital
	A teaching Affliate of Harvard Medical School
Home About Us Services Research Education Staff For Patient For Medical Professional Alumni Anatomic Pathology Clinical Laboratories Blood Bank Cytogenetics About Our Research CMOP Histopathology Core Virtual Specimen Locator Biospecimen banking Vascular Research Division DGAP Project Center for Uterine Fibroids Residency AP Program CP program Fellowships CME Faculty Residents and Fellows Administration Patient Resources Referral Information Useful Links Referral Information Calendar and Events Education and Training Sign Out Forms Surg Path Manual Powerpath instructions Useful Links

Name and Present Position:

RONNY I. DRAPKIN, Pathologist

http://www.hms.harvard.edu/dms/bbs/fac/Drapkin.html

Address:

Dana-Farber Cancer Institute, 44 Binney Street, CMOP-JF215D, Boston, MA

Medical School (including school, date and degree awarded):

1996 PhD, University of Medicine and Dentistry of New Jersey, Piscataway, NJ
1998 MD, University of Medicine and Dentistry of New Jersey, Piscataway, NJ

Graduate Medical Education (including dates and institution of internships, residencies, fellowships, etc.):

1998-2001 Resident in Anatomic Pathology, Brigham and Women's Hospital, Boston, MA
2001-2005 Research Fellowship, Dana-Farber Cancer Institute, Boston, MA

Current Academic Appointment:

Assistant Professor in Pathology, Harvard Medical School

Current Medical Staff Appointment(s):

Pathologist, Brigham and Women's Hospital
Associate Member, Center for Molecular Pathology, DFCI-BWH
Principal Investigator/Scientist, Dana Farber Cancer Institute, Boston, MA

Selected Bibliography:

Drapkin R, Crum CP, Hecht JL. Expression of Candidate Tumor Markers in Ovarian Carcinoma and Benign Ovary: Evidence for a link between epithelial phenotype and neoplasia. Human Pathol 2004; 35: 1014-1021.
Cantor S*, Drapkin R*, Zhang F, Lin Y, Han J, Pamidi S, Livingston DM. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. PNAS 2004; 101: 2357-2362. (* denotes equal contribution).
Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, Hecht JL. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 2005; 65: 2162-2169.
Drapkin R, Hecht JL. Pathogenesis of Ovarian Cancer in Diagnostic Gynecologic and Obstetric Pathology [Crum CP and Lee KR, eds.], W.B. Saunders, Philadelphia, 2006.
Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007, 211:26-35.
Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, Lee Y. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007; 19: 3-9.
Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, Mannermaa A, Kallioniemi A, Pylkas K, Karppinen S-M, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma V-M, Soini Y, Drapkin RI, Livingston DM, Winqvist R. A recurrent mutation in PALB2 in Finnish cancer families. Nature 2007; 446: 316-319.